Finance minister questions Raiffeisen board pay rise
Keystone
Swiss finance minister Ueli Maurer has criticized the board of Raiffeisen bank for awarding itself a 40% pay rise at a time when its former CEO is facing criminal proceedings for suspected corporate fraud.
This content was published on
1 minute
SDA-ATS/jc
In an interview published by the Zentralschweiz am Sonntag and Ostschweiz am Sonntag newspapers, Maurer said he did not understand the decision and that it was not sensible. However, he added that it was not up to the government to interfere.
In early March, Raiffeisen’s former CEO Pierin Vincenz was arrested and put under criminal proceedings for corporate fraud, and the chairman of the board stepped down over the affair.
The troubles at Raiffeisen are unpleasant, and the case harms the entire financial centre, because it damages trust, the minister told the newspapers.
Maurer added that he had not identified any failings in financial market oversight. The bank is also facing proceedings from the Financial Market Supervisory Authority (FINMA).
The minister said he would now wait for the results of the criminal investigation.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Raiffeisen chair resigns over scandal-tainted former CEO
This content was published on
A statementExternal link released by the bank on Thursday, said the move was intended to “preserve the long-term credibility of the bank”. Rüegg-Stürm’s resignation “will open the path to renewal of the board” it added. Board vice-president Pascal Gantenbein will assume interim charge of the board until a replacement can be found. “My priority task…
Former Raiffeisen boss Vincenz faces criminal probe
This content was published on
“Raiffeisen is therefore making a maximum contribution to the complete clarification of all processes,” the bank said in a statement on Wednesday. Vincenz has been dogged by suspicions of conflict of interest during his tenure as Raiffeisen boss, during which he personally invested in subsidiaries of the banking group. There have also been questions surrounding…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.